Report Detail
Global Anti-α4β7 Integrin Monoclonal Antibody Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4735359 |
- 24 August, 2026 |
- Global |
- 71 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Anti-α4β7 Integrin Monoclonal Antibody market size was valued at US$ 10350 million in 2025 and is forecast to a readjusted size of US$ 19020 million by 2032 with a CAGR of 9.2% during review period.
Anti-α4β7 integrin monoclonal antibodies are a class of therapeutic agents that specifically target and inhibit the α4β7 integrin, a receptor found on lymphocytes that is involved in the migration of these immune cells to the gastrointestinal tract. By blocking this integrin, these monoclonal antibodies prevent lymphocytes from adhering to the vascular endothelium in the gut, thereby reducing inflammation in conditions like Crohn's disease and ulcerative colitis.
This report is a detailed and comprehensive analysis for global Anti-α4β7 Integrin Monoclonal Antibody market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Anti-α4β7 Integrin Monoclonal Antibody market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Anti-α4β7 Integrin Monoclonal Antibody market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Anti-α4β7 Integrin Monoclonal Antibody market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Anti-α4β7 Integrin Monoclonal Antibody market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anti-α4β7 Integrin Monoclonal Antibody
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anti-α4β7 Integrin Monoclonal Antibody market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, Biogen, Sandoz, Novartis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Anti-α4β7 Integrin Monoclonal Antibody market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Natalizumub
Vedolizumab
Market segment by Application
Inflammatory Bowel Disease (IBD)
Multiple Sclerosis (MS)
Other
Major players covered
Takeda
Biogen
Sandoz
Novartis
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-α4β7 Integrin Monoclonal Antibody product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anti-α4β7 Integrin Monoclonal Antibody, with price, sales quantity, revenue, and global market share of Anti-α4β7 Integrin Monoclonal Antibody from 2021 to 2026.
Chapter 3, the Anti-α4β7 Integrin Monoclonal Antibody competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-α4β7 Integrin Monoclonal Antibody breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Anti-α4β7 Integrin Monoclonal Antibody market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-α4β7 Integrin Monoclonal Antibody.
Chapter 14 and 15, to describe Anti-α4β7 Integrin Monoclonal Antibody sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Anti-α4β7 Integrin Monoclonal Antibody Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Natalizumub
- 1.3.3 Vedolizumab
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Anti-α4β7 Integrin Monoclonal Antibody Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Inflammatory Bowel Disease (IBD)
- 1.4.3 Multiple Sclerosis (MS)
- 1.4.4 Other
- 1.5 Global Anti-α4β7 Integrin Monoclonal Antibody Market Size & Forecast
- 1.5.1 Global Anti-α4β7 Integrin Monoclonal Antibody Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Anti-α4β7 Integrin Monoclonal Antibody Sales Quantity (2021-2032)
- 1.5.3 Global Anti-α4β7 Integrin Monoclonal Antibody Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Takeda
- 2.1.1 Takeda Details
- 2.1.2 Takeda Major Business
- 2.1.3 Takeda Anti-α4β7 Integrin Monoclonal Antibody Product and Services
- 2.1.4 Takeda Anti-α4β7 Integrin Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Takeda Recent Developments/Updates
- 2.2 Biogen
- 2.2.1 Biogen Details
- 2.2.2 Biogen Major Business
- 2.2.3 Biogen Anti-α4β7 Integrin Monoclonal Antibody Product and Services
- 2.2.4 Biogen Anti-α4β7 Integrin Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Biogen Recent Developments/Updates
- 2.3 Sandoz
- 2.3.1 Sandoz Details
- 2.3.2 Sandoz Major Business
- 2.3.3 Sandoz Anti-α4β7 Integrin Monoclonal Antibody Product and Services
- 2.3.4 Sandoz Anti-α4β7 Integrin Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Sandoz Recent Developments/Updates
- 2.4 Novartis
- 2.4.1 Novartis Details
- 2.4.2 Novartis Major Business
- 2.4.3 Novartis Anti-α4β7 Integrin Monoclonal Antibody Product and Services
- 2.4.4 Novartis Anti-α4β7 Integrin Monoclonal Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Novartis Recent Developments/Updates
3 Competitive Environment: Anti-α4β7 Integrin Monoclonal Antibody by Manufacturer
- 3.1 Global Anti-α4β7 Integrin Monoclonal Antibody Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Anti-α4β7 Integrin Monoclonal Antibody Revenue by Manufacturer (2021-2026)
- 3.3 Global Anti-α4β7 Integrin Monoclonal Antibody Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Anti-α4β7 Integrin Monoclonal Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Anti-α4β7 Integrin Monoclonal Antibody Manufacturer Market Share in 2025
- 3.4.3 Top 6 Anti-α4β7 Integrin Monoclonal Antibody Manufacturer Market Share in 2025
- 3.5 Anti-α4β7 Integrin Monoclonal Antibody Market: Overall Company Footprint Analysis
- 3.5.1 Anti-α4β7 Integrin Monoclonal Antibody Market: Region Footprint
- 3.5.2 Anti-α4β7 Integrin Monoclonal Antibody Market: Company Product Type Footprint
- 3.5.3 Anti-α4β7 Integrin Monoclonal Antibody Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Anti-α4β7 Integrin Monoclonal Antibody Market Size by Region
- 4.1.1 Global Anti-α4β7 Integrin Monoclonal Antibody Sales Quantity by Region (2021-2032)
- 4.1.2 Global Anti-α4β7 Integrin Monoclonal Antibody Consumption Value by Region (2021-2032)
- 4.1.3 Global Anti-α4β7 Integrin Monoclonal Antibody Average Price by Region (2021-2032)
- 4.2 North America Anti-α4β7 Integrin Monoclonal Antibody Consumption Value (2021-2032)
- 4.3 Europe Anti-α4β7 Integrin Monoclonal Antibody Consumption Value (2021-2032)
- 4.4 Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Consumption Value (2021-2032)
- 4.5 South America Anti-α4β7 Integrin Monoclonal Antibody Consumption Value (2021-2032)
- 4.6 Middle East & Africa Anti-α4β7 Integrin Monoclonal Antibody Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Anti-α4β7 Integrin Monoclonal Antibody Sales Quantity by Type (2021-2032)
- 5.2 Global Anti-α4β7 Integrin Monoclonal Antibody Consumption Value by Type (2021-2032)
- 5.3 Global Anti-α4β7 Integrin Monoclonal Antibody Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Anti-α4β7 Integrin Monoclonal Antibody Sales Quantity by Application (2021-2032)
- 6.2 Global Anti-α4β7 Integrin Monoclonal Antibody Consumption Value by Application (2021-2032)
- 6.3 Global Anti-α4β7 Integrin Monoclonal Antibody Average Price by Application (2021-2032)
7 North America
- 7.1 North America Anti-α4β7 Integrin Monoclonal Antibody Sales Quantity by Type (2021-2032)
- 7.2 North America Anti-α4β7 Integrin Monoclonal Antibody Sales Quantity by Application (2021-2032)
- 7.3 North America Anti-α4β7 Integrin Monoclonal Antibody Market Size by Country
- 7.3.1 North America Anti-α4β7 Integrin Monoclonal Antibody Sales Quantity by Country (2021-2032)
- 7.3.2 North America Anti-α4β7 Integrin Monoclonal Antibody Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Anti-α4β7 Integrin Monoclonal Antibody Sales Quantity by Type (2021-2032)
- 8.2 Europe Anti-α4β7 Integrin Monoclonal Antibody Sales Quantity by Application (2021-2032)
- 8.3 Europe Anti-α4β7 Integrin Monoclonal Antibody Market Size by Country
- 8.3.1 Europe Anti-α4β7 Integrin Monoclonal Antibody Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Anti-α4β7 Integrin Monoclonal Antibody Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Market Size by Region
- 9.3.1 Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Anti-α4β7 Integrin Monoclonal Antibody Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Anti-α4β7 Integrin Monoclonal Antibody Sales Quantity by Type (2021-2032)
- 10.2 South America Anti-α4β7 Integrin Monoclonal Antibody Sales Quantity by Application (2021-2032)
- 10.3 South America Anti-α4β7 Integrin Monoclonal Antibody Market Size by Country
- 10.3.1 South America Anti-α4β7 Integrin Monoclonal Antibody Sales Quantity by Country (2021-2032)
- 10.3.2 South America Anti-α4β7 Integrin Monoclonal Antibody Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Anti-α4β7 Integrin Monoclonal Antibody Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Anti-α4β7 Integrin Monoclonal Antibody Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Anti-α4β7 Integrin Monoclonal Antibody Market Size by Country
- 11.3.1 Middle East & Africa Anti-α4β7 Integrin Monoclonal Antibody Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Anti-α4β7 Integrin Monoclonal Antibody Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Anti-α4β7 Integrin Monoclonal Antibody Market Drivers
- 12.2 Anti-α4β7 Integrin Monoclonal Antibody Market Restraints
- 12.3 Anti-α4β7 Integrin Monoclonal Antibody Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Anti-α4β7 Integrin Monoclonal Antibody and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Anti-α4β7 Integrin Monoclonal Antibody
- 13.3 Anti-α4β7 Integrin Monoclonal Antibody Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Anti-α4β7 Integrin Monoclonal Antibody Typical Distributors
- 14.3 Anti-α4β7 Integrin Monoclonal Antibody Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Anti-α4β7 Integrin Monoclonal Antibody. Industry analysis & Market Report on Anti-α4β7 Integrin Monoclonal Antibody is a syndicated market report, published as Global Anti-α4β7 Integrin Monoclonal Antibody Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Anti-α4β7 Integrin Monoclonal Antibody market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
